The document summarizes feasibility checklists received from CRO firms, sponsor firms, and according to month and indication from April 2020 to March 2021. It reports that a total of 127 checklists were received from domestic and international CRO firms, and 35 from domestic and international sponsor firms. The highest numbers of checklists came from Veeda Clinical Research (19) and IQVIA (51). Checklist numbers varied by month, with the highest in November 2020 (23). By indication, oncology had the most at 30, while infectious disease and dermatology each had over 15.

1. Feasibility Checklists
From April 2020 to March 2021

2. Index
1. CRO and Sponsor Firm Feasibility
Checklists.
2. Feasibility Checklist Received from
Veeda Clinical Research And IQVIA.
3. Feasibility Checklist according to Month
wise.
4. Feasibility Checklist according to
Indications

3. CRO and Sponsor Firm Feasibility
Checklists
 Total feasibility checklist received from CRO Firm = 127
a) Domestic CRO Firm = 53
b) International CRO Firm = 15
 Total feasibility checklist received from Sponsor Firm = 35
a) Domestic Sponsor Firm = 74
b) International Sponsor Firm = 25

4. CRO and Sponsor Firm Feasibility
Checklist Graphic representation
127
53
74
35
25
15
0
20
40
60
80
100
120
140
Total CRO
Feasibility
Domestic
CRO
International
CRO
TOTAL
SPONSOR
Feasibility
Domestic
sponsor
International
sponsor
Total Feasibility
Series1

5. Feasibility Checklist Received from
Veeda Clinical Research And IQVIA
 From Veeda Clinical Research = 19
 From IQVIA = 51
1
51
19

6. Feasibility Checklist according to
Month wise
Months No. of Feasibility Checklist
Received
April 2020 7
May 2020 6
June 2020 7
July 2020 16
August 2020 12
September 2020 18
October 2020 9
November 2020 23
December 2020 16
January 2021 19
February 2021 11
March 2021 16
Total 160

7. Feasibility Checklist according to
Month wise Graphic representation
0
5
10
15
20
25
7 6 7
16
12
18
9
23
16
19
11
16

8. Feasibility Checklist according to
Indications
Indications No. of Feasibility
Checklist Received
Asthma 15
Cardiology 1
Dermatology 18
Endocrinology 3
Gastroenterology 4
General Medicine 5
Gynecology and
Obstetric 7
infectious diease 20
Indications No. of Feasibility
Checklist
Received
Nephrology 5
Neurology 4
Oncology 30
Opthalmology 2
Orthopedics 4
Pediatric 8
Pediatric
Endocrinology 7
Psychiatry 4
Rheumatology 8

9. Feasibility Checklist according to
Indications Graphic representation
0
5
10
15
20
25
30

10. Thank You